Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
NCT07700758 Belzutifan Solid tumor Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07700758 Belzutifan Solid tumor Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into NCT07700758, evaluating Belzutifan in Solid tumor: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
NCT07703436 DS-1001 IDH1-mutant Glioma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07703436 DS-1001 IDH1-mutant Glioma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into NCT07703436, evaluating DS-1001 in IDH1-mutant Glioma: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
CTR20262664 SYS6041 Recurrent ovarian cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262664 SYS6041 Recurrent ovarian cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into CTR20262664, evaluating SYS6041 in Recurrent ovarian cancer: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
CTR20262679 JYP0066 一项评估JYP0066外用乳膏在青少年和成人轻中度特应性皮炎患者中有效性和安全性的临床研究 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262679 JYP0066 一项评估JYP0066外用乳膏在青少年和成人轻中度特应性皮炎患者中有效性和安全性的临床研究 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into CTR20262679, evaluating JYP0066 in 一项评估JYP0066外用乳膏在青少年和成人轻中度特应性皮炎患者中有效性和安全性的临床研究: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
CTR20262688 VC-005 Alopecia Areata Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262688 VC-005 Alopecia Areata Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into CTR20262688, evaluating VC-005 in Alopecia Areata: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
CTR20262708 Sacituzumab tirumotecan SKB264联合SKB118治疗非小细胞肺癌参与者的Ⅱ期临床研究 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262708 Sacituzumab tirumotecan SKB264联合SKB118治疗非小细胞肺癌参与者的Ⅱ期临床研究 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into CTR20262708, evaluating Sacituzumab tirumotecan in SKB264联合SKB118治疗非小细胞肺癌参与者的Ⅱ期临床研究: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
JPRN-jRCT2033260314 Investigational Regimen Hemophilia B Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
JPRN-jRCT2033260314 Investigational Regimen Hemophilia B Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into JPRN-jRCT2033260314, evaluating Investigational Regimen in Hemophilia B: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
NCT07704684 Sacubitril Essential Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07704684 Sacubitril Essential Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into NCT07704684, evaluating Sacubitril in Essential Hypertension: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
NCT07704697 Sacubitril Essential Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07704697 Sacubitril Essential Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into NCT07704697, evaluating Sacubitril in Essential Hypertension: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
ChiCTR2600128203 Sigvotatug vedotin Non-Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
ChiCTR2600128203 Sigvotatug vedotin Non-Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into ChiCTR2600128203, evaluating Sigvotatug vedotin in Non-Small Cell Lung Cancer: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
NCT07706582 Iron Dextran Kidney Failure Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07706582 Iron Dextran Kidney Failure Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into NCT07706582, evaluating Iron Dextran in Kidney Failure: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Read →
ChiCTR2600128248 hyperbaric oxygen therapy Metastatic breast cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
ChiCTR2600128248 hyperbaric oxygen therapy Metastatic breast cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 July 2026
A focused 2026 clinical landscape deep dive into ChiCTR2600128248, evaluating hyperbaric oxygen therapy in Metastatic breast cancer: design, endpoints, sponsor context, readout timing and white space.
Read →